Literature DB >> 28281492

Comorbidities of epilepsy.

H V Srinivas1, Urvashi Shah2.   

Abstract

In epilepsy management, control of seizures is the prime objective. However, the quality of life is affected by comorbid conditions that include the neurological, neuropsychiatric, and neurobehavioural disorders. These are not only reactive processes to a chronic condition but also have a bidirectional relationship, sharing common underlying pathogenesis. This article besides addressing these issues also explores the therapeutic management. A systematic search of PubMed from Jan 2006 to August 2016 was undertaken using the terms "comorbidities" and "epilepsy." In addition, articles specifically from India and other original papers were selected based on relevance. In this review, the neuropsychiatric, neurobehavioral (mood disorders, behaviour issues, attention deficits, psychosis), and neurologic [cognitive impairment, migraine, SUDEP-Sudden unexpected death in epilepsy (SUDEP)] comorbidities are covered in relation to epilepsy and its treatment. The incidental disorders such as hypertension, diabetes, and cancer that are mentioned in some reports have not been addressed here. Comorbidities in epilepsy are common but poorly understood and often remain unaddressed. The prevalence of comorbid conditions is considerably higher in epilepsy than seen in the general population and other chronic conditions. There is a wide spectrum of secondary disorders that have a marked impact and significantly increase the burden of the primary epilepsy condition. There is a need to acknowledge, screen, and intervene early in newly diagnosed cases for the optimal management of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28281492     DOI: 10.4103/neuroindia.NI_922_16

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

1.  Management of Psychiatric Disorders in Patients of Epilepsy.

Authors:  Jahnavi S Kedare; Sachin P Baliga
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

Review 2.  Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy.

Authors:  Samantha L Hodges; Joaquin N Lugo
Journal:  Epilepsy Res       Date:  2020-01-30       Impact factor: 2.991

3.  Pleiotropy of polygenic factors associated with focal and generalized epilepsy in the general population.

Authors:  Costin Leu; Tom G Richardson; Tobias Kaufmann; Dennis van der Meer; Ole A Andreassen; Lars T Westlye; Robyn M Busch; George Davey Smith; Dennis Lal
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

Review 4.  Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.

Authors:  Beatriz Gil; Jonathon Smith; Yong Tang; Peter Illes; Tobias Engel
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

Review 5.  Serotonin receptors in epilepsy: Novel treatment targets?

Authors:  Jo Sourbron; Lieven Lagae
Journal:  Epilepsia Open       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.